FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

96363002: Tetracosactide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2002. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
159482016 Cosyntropin en Synonym Active Entire term case insensitive SNOMED CT core module
159483014 Tetracosactide en Synonym Active Entire term case insensitive SNOMED CT core module
159484015 Tetracosactrin en Synonym Active Entire term case insensitive SNOMED CT core module
159485019 Tetracosactin en Synonym Active Entire term case insensitive SNOMED CT core module
3484962012 Tetracosactide (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tetracosactide Is a Adrenocorticotropic hormone false Inferred relationship Existential restriction modifier
Tetracosactide Is a Corticotropin preparation false Inferred relationship Existential restriction modifier
Tetracosactide Is a Corticotropic agent false Inferred relationship Existential restriction modifier
Tetracosactide Is a Synthetic hormone agent false Inferred relationship Existential restriction modifier
Tetracosactide Has disposition Anterior pituitary hormone true Inferred relationship Existential restriction modifier
Tetracosactide Is a Adrenocorticotropic hormone and/or adrenocorticotropic hormone derivative true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cosyntropin preparation Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactrin adverse reaction Causative agent True Tetracosactide Inferred relationship Existential restriction modifier 1
Allergy to tetracosactrin Causative agent False Tetracosactide Inferred relationship Existential restriction modifier
Product containing tetracosactide Has active ingredient True Tetracosactide Inferred relationship Existential restriction modifier 1
Tetracosactrin 250micrograms/1mL injection Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactrin 1mg/1mL injection Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Cosyntropin 50mcg/mannitol 10mg injection solution vial Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Cosyntropin 25mcg/mannitol 10mg injection solution vial Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactide acetate Is a False Tetracosactide Inferred relationship Existential restriction modifier
Allergy to tetracosactrin Causative agent True Tetracosactide Inferred relationship Existential restriction modifier 1
Tetracosactide acetate Is modification of True Tetracosactide Inferred relationship Existential restriction modifier
Product containing tetracosactide in parenteral dose form (medicinal product form) Has active ingredient True Tetracosactide Inferred relationship Existential restriction modifier 1
Tetracosactide Has active ingredient True Tetracosactide Inferred relationship Existential restriction modifier 1
Product containing only tetracosactide in parenteral dose form (medicinal product form) Has active ingredient True Tetracosactide Inferred relationship Existential restriction modifier 1
Product containing precisely tetracosactide (as tetracosactide acetate) 250 microgram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Tetracosactide Inferred relationship Existential restriction modifier 1
Tetracosactide 250micrograms/1mL injection - product Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactide 1mg/1mL injection - product Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactrin 2mg/2mL injection Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1mL injection Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Synacthen Depot 1mg/1mL injection Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Synacthen Depot 2mg/2mL injection Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactide acetate Is a False Tetracosactide Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) Has active ingredient True Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) 5 ampoule Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactide 1mg/1ml suspension for injection ampoules Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Synacthen Depot 1mg/1ml suspension for injection ampoules (Atnahs Pharma UK Ltd) Has active ingredient True Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules Has active ingredient False Tetracosactide Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start